课题基金 / 基金详情

Developmental Factors for Reducing Dopamine Loss in Primate Models of PD & Aging

Developmental Factors for Reducing Dopamine Loss in Primate Models of PD & Aging
减少灵长类 PD 模型中多巴胺损失的发育因素
批准号:
9896741
负责人:
JOHN D ELSWORTH
金额:
$47.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-01 至 2023-03-31

项目摘要

项目成果

JOHN D ELSWORTH的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):在正常人脑中,中脑多巴胺能神经元的数量每十年福尔斯约3-5%,而在帕金森病(PD)中,这种下降要大得多。这种对前脑区域的多巴胺(DA)神经支配的无情丧失与运动和认知功能的下降密切相关。尽管知道氧化应激是PD和衰老中DA神经元功能丧失的关键共谋者,但没有治疗方法来阻止DA神经元的磨损。这一问题的部分原因是, 动物模型成年DA神经元对MPTP或甲基苯丙胺(METH)产生的帕金森样氧化应激非常敏感,但我们的研究小组已经证明,在生命早期的有限时期,灵长类动物的大脑对这种损伤具有显著的抵抗力。这为DA神经元提供了一种新的神经保护模型,具有对氧化损伤的“内置”弹性。这种针对MPTP或METH的保护窗口的存在不能用药物水平的改变或药物毒性作用所必需的关键转运蛋白或酶的不成熟来解释。该项目的目标是了解保护年轻灵长类DA神经元免受氧化应激的因素和机制,并利用这些知识为生命后期脆弱阶段的DA神经元提供保护。这种方法有望取得成功,因为它依赖于恢复现存的抗氧化机制,而不是试图使用可能操纵非生理生化信号的药物来保护DA神经元。我们已经确定了两个潜在的“青少年保护因子”,它们优先在年轻的灵长类动物脑中表达,并具有强的抗氧化特性;解偶联蛋白-2(UCP 2)和对氧磷酶-2(PON 2)。一个目的是测试UCP 2在减轻线粒体活性氧水平和随后对年轻DA神经元的损伤中起主要作用,并且5'腺苷一磷酸活化蛋白激酶(AMPK)活性调节UCP 2的假设。另一个目的是研究保护成年DA神经元免受诱导的氧化应激,这是通过使用新的药物在体内激活UCP 2表达来实现的。对PON 2的了解比UCP 2少,最终的目标是测试关于其调节及其在保护年轻灵长类DA神经元免受氧化应激损伤中的作用的假设,并且还将检查PON 2表达在成人中的上调在多大程度上提供对DA神经元体内氧化应激的保护。此外,我们将继续研究灵长类动物大脑中这些青少年保护因子表达的男女差异,因为这可能与女性受试者PD发病率较低有关,也提供了诱导DA神经元保护的新方法。这项建议将采用生物化学,组织化学和药理学研究在长尾猴这些新的方向。DA神经元发育中关键里程碑的时间显示出重要的物种差异,因此这些灵长类动物研究具有特定的翻译相关性。这项研究有望刺激新的方法来预防DA依赖性年龄相关疾病的发生或进展。
英文摘要
 DESCRIPTION (provided by applicant): In normal human brain the population of midbrain dopaminergic neurons falls by about 3-5% every decade, while in Parkinson's disease (PD) this decline is much greater. This inexorable loss of dopamine (DA) innervation to forebrain regions has been firmly linked with declines in both motor and cognitive functions. Despite knowing that oxidative stress is a key conspirator in the loss of DA neuron function in PD and aging, there are no treatments to halt the attrition of DA neurons. Part of this problem is due to the inadequacy of animal models. Adult DA neurons are very susceptible to the parkinsonian-like oxidative stress exerted by either MPTP or methamphetamine (METH), but our group has demonstrated that for a restricted period early in life, the primate brain is remarkably resistant to such damage. This provides a new neuroprotection model for DA neurons, possessing "built-in" resilience to oxidative damage. The existence of this window of protection against MPTP or METH cannot be explained by altered drug levels, or by immaturity of key transporters or enzymes necessary for the toxic effect of the drugs. The goal of this project is to understand the factors and mechanisms shielding young primate DA neurons from oxidative stress and use this knowledge to provide protection to DA neurons at the later vulnerable stages of life. This approach promises to be successful as it relies on reinstating extant anti-oxidant mechanisms, rather than attempting to protect DA neurons using drugs that may manipulate biochemical signaling non-physiologically. We have identified 2 potential "juvenile protection factors" that are preferentialy expressed in the young primate brain and have strong anti-oxidant properties; uncoupling protein-2 (UCP2) and paraoxonase-2 (PON2). One aim tests the hypothesis that UCP2 plays a major role in mitigating the level of mitochondrial reactive oxygen species and subsequent damage to young DA neurons, and that 5' adenosine monophosphate-activated protein kinase (AMPK) activity regulates UCP2. Another aim examines the protection against induced oxidative stress in adult DA neurons that is achieved by using novel agents to activate UCP2 expression in vivo. Less is known about PON2 than UCP2, and the final aim will test hypotheses about its regulation and its role in protecting young primate DA neurons against oxidative stress damage, and will also examine to what extent up-regulation of PON2 expression in the adult affords protection against in vivo oxidative stress in DA neurons. In addition, we will pursue our data on male-female differences in expression of these juvenile protection factors in primate brain, as this may relate to the lower incidence of PD in female subjects and also provide new ways to induce protection in DA neurons. This proposal will pursue these novel directions using biochemical, histochemical, and pharmacological studies in vervet monkeys. The timing of critical milestones in developing DA neurons display important species differences, so these primate studies have particular translational relevance. This research is expected to stimulate new approaches to prevent the occurrence or progression of DA-dependent age-related disorders.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Expression of PON2 isoforms varies among brain regions in male and female African green monkeys.
在男性和女性非洲绿猴中,PON2同工型的表达在大脑区域之间有所不同。
DOI: 10.1016/j.freeradbiomed.2021.12.005
发表时间: 2022-01
期刊: Free radical biology & medicine
影响因子: 7.4
作者: [Jamwal S, Blackburn JK, Elsworth JD]
通讯作者: Elsworth JD
DOI: 10.1007/s00702-020-02167-1
发表时间: 2020-05
期刊: Journal of neural transmission (Vienna, Austria : 1996)
影响因子: --
作者: [Elsworth JD]
通讯作者: Elsworth JD
DOI: 10.1186/s13293-023-00551-6
发表时间: 2023-09-28
期刊: BIOLOGY OF SEX DIFFERENCES
影响因子: 7.9
作者: [Jamwal, Sumit, Blackburn, Jennifer K., Elsworth, John D.]
通讯作者: Elsworth, John D.
DOI: 10.1016/j.pharmthera.2020.107705
发表时间: 2021-03
期刊: Pharmacology & therapeutics
影响因子: 13.5
作者: [Jamwal S, Blackburn JK, Elsworth JD]
通讯作者: Elsworth JD
共 7 条
    Biochemical and Synaptic Mechanisms in Prefrontal Cortex and Vulnerability for Cognitive Deficits
    • 批准号:
      9888424
    • 项目类别:
    • 资助金额:
      $62.25万
    • 财政年份:
      2016
    • 负责人:
      JOHN D ELSWORTH
    • 依托单位:
    Developmental Factors for Reducing Dopamine Loss in Primate Models of PD & Aging
    • 批准号:
      9027986
    • 项目类别:
    • 资助金额:
      $47.32万
    • 财政年份:
      2016
    • 负责人:
      JOHN D ELSWORTH
    • 依托单位:
    Dopamine Modulation of Cortical Spine Synapses and Cognition in MPTP Monkeys
    • 批准号:
      8300952
    • 项目类别:
    • 资助金额:
      $42.12万
    • 财政年份:
      2010
    • 负责人:
      JOHN D ELSWORTH
    • 依托单位:
    Dopamine Modulation of Cortical Spine Synapses and Cognition in MPTP Monkeys
    • 批准号:
      7885212
    • 项目类别:
    • 资助金额:
      $42.55万
    • 财政年份:
      2010
    • 负责人:
      JOHN D ELSWORTH
    • 依托单位:
    海外基金